[68Ga]Ga-PSMA-11 SUVmeanat tumor sites was predictive of response to [177Lu]Lu-PSMA therapy, and [18F]FDG PET tumor volume was prognostic.16An imaging data repository to collect DICOM files from multiple trial sites for review and analysis is therefore a critical component of clinical trials with theranostics. The gene discussed is FOLH1; the disease is neoplasm.